Pharmaceutical development of ondansetron tablets

Area of Science:

• Pharmaceutical Sciences
• Drug Formulation
• Quality Control

Background:

• Ondansetron is a widely used antiemetic medication.
• Ensuring consistent drug content and release from tablet formulations is crucial for efficacy.
• Manufacturing processes can impact drug uniformity and stability.

Purpose of the Study:

• To evaluate the content uniformity and drug content of ondansetron tablets throughout the compression process.
• To investigate the relationship between tablet disintegration time and drug release kinetics.
• To assess the stability and determine the shelf life of ondansetron tablets.

Main Methods:

• Analysis of ondansetron tablets sampled at the beginning and end of the compression process.
• Measurement of tablet disintegration times.
• In vitro drug release studies.
• Stability testing under specified storage conditions.

Main Results:

• Tablets demonstrated good content uniformity and drug content, indicating no segregation or loss during tabletting.
• A direct correlation was observed between tablet disintegration time and drug release rate.
• Tablets with 3-minute disintegration released 85% drug in ~6 minutes; 10-minute disintegration released 85% drug in ~20 minutes.
• Satisfactory bioavailability was confirmed.
• Tablets exhibited good stability with a shelf life of 2 years when stored below 30°C.

Conclusions:

• The manufacturing process for ondansetron tablets ensures consistent drug content and uniformity.
• Tablet disintegration time is a critical factor controlling ondansetron release kinetics.
• Ondansetron tablets possess favorable bioavailability, stability, and a 2-year shelf life, making them a reliable pharmaceutical product.